Direct real-time PCR-based detection of Neisseria gonorrhoeae 23S rRNA mutations associated with azithromycin resistance

The Journal of Antimicrobial Chemotherapy
Ella TrembizkiDavid Whiley

Abstract

Surveillance for Neisseria gonorrhoeae azithromycin resistance is of growing importance given increasing use of ceftriaxone and azithromycin dual therapy for gonorrhoea treatment. In this study, we developed two real-time PCR methods for direct detection of two key N. gonorrhoeae 23S rRNA mutations associated with azithromycin resistance. The real-time PCR assays, 2611-PCR and 2059-PCR, targeted the gonococcal 23S rRNA C2611T and A2059G mutations, respectively. A major design challenge was that gonococcal 23S rRNA sequences have high sequence homology with those of commensal Neisseria species. To limit the potential for cross-reaction, 'non-template' bases were utilized in primer sequences. The performance of the methods was initially assessed using a panel of gonococcal (n = 70) and non-gonococcal (n = 28) Neisseria species. Analytical specificity was further assessed by testing N. gonorrhoeae nucleic acid amplification test (NAAT)-negative clinical samples (n = 90), before being applied to N. gonorrhoeae NAAT-positive clinical samples (n = 306). Cross-reactions with commensal Neisseria strains remained evident for both assays; however, cycle threshold (Ct) values were significantly delayed, indicating reduced sensitivity for ...Continue Reading

References

Oct 3, 1999·Antimicrobial Agents and Chemotherapy·L ZarantonelliW M Shafer
Aug 17, 2002·Antimicrobial Agents and Chemotherapy·Lai-King NgLouis Bryden
Jun 17, 2008·The Journal of Antimicrobial Chemotherapy·Helen M PalmerJayshree Dave
Apr 10, 2009·The Journal of Antimicrobial Chemotherapy·S StarninoUNKNOWN Neisseria gonorrhoeae Italian Study Group
Sep 8, 2009·Sexually Transmitted Diseases·Patricia G GalarzaJulio A Vázquez
Oct 22, 2009·Sexually Transmitted Infections·David M WhileyJohn W Tapsall
Jun 30, 2010·Antimicrobial Agents and Chemotherapy·Stephanie A ChisholmCatherine A Ison
Dec 21, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alan R KatzKing K Holmes
Dec 13, 2012·Future Microbiology·Magnus Unemo, Robert A Nicholas
Oct 5, 2013·Journal of Medical Microbiology·Ella Trembizki On Behalf Of 'grand' Study Investigators
Feb 11, 2014·Nature Reviews. Microbiology·Namraj GoireDavid M Whiley
May 20, 2014·Journal of Medical Microbiology·Ella Trembizki On Behalf Of The Grand Study Investigators
Jul 2, 2014·Clinical Microbiology Reviews·Magnus Unemo, William M Shafer
Nov 6, 2014·The New England Journal of Medicine·Monica M LahraDavid M Whiley
Nov 14, 2014·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·B BercotE Cambau
Dec 7, 2014·The Journal of Antimicrobial Chemotherapy·Kerrie StevensBenjamin P Howden

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.